首页> 外文OA文献 >PUK9 COST-EFFECTIVENESS ANALYSIS OF ALPHA-BLOCKER AND ANTIMUSCARINIC COMBINATION TREATMENT IN MEN WITH LOWER URINARY TRACT SYMPTOMS RELATED TO BENIGN PROSTATIC HYPERPLASIA AND OVERACTIVE BLADDER: APPLICATION TO THE UNITED KINGDOM

【2h】

PUK9 COST-EFFECTIVENESS ANALYSIS OF ALPHA-BLOCKER AND ANTIMUSCARINIC COMBINATION TREATMENT IN MEN WITH LOWER URINARY TRACT SYMPTOMS RELATED TO BENIGN PROSTATIC HYPERPLASIA AND OVERACTIVE BLADDER: APPLICATION TO THE UNITED KINGDOM

机译：与前列腺肥大和膀胱过度活动症相关的下尿路症状较低的男性中α-受体阻滞剂和抗绝症联合疗法的PUK9成本效益分析：在英国的应用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Verheggen BG; Lee R; Treur MJ; Heeg B; Botteman M; Mollon P; Trocio JN; Bavendam T; Kaplan S;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The Efficacy of PDE5 Inhibitors Alone or in Combination with Alpha-Blockers for the Treatment of Erectile Dysfunction and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis [J] . Yan Huilei, Zong Huantao, Cui Yuanshan, The journal of sexual medicine . 2014,第6期

机译：PDE5抑制剂单独或与α-受体阻滞剂联合治疗因良性前列腺增生引起的勃起功能障碍和下尿路症状的疗效：系统评价和荟萃分析
2. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both? [J] . Carson CC BJU international . 2006,第Suppla2期

机译：良性前列腺增生患者中磷酸二酯酶5抑制剂和α受体阻滞剂的组合：下尿路症状，勃起功能障碍或两者的治疗？
3. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study. [J] . Yokoyama T, Uematsu K, Watanabe T, Scandinavian journal of urology and nephrology . 2009,第4期

机译：萘甲托地尔和盐酸普罗维汀治疗男性下尿路症状提示前列腺增生和膀胱过度活动症：一项前瞻性随机对照研究。
4. Analysis of glycoforms of urinary prostate-specific antigen of prostate cancer and benign prostate hyperplasia samples [C] . Chun-Jen Hsiao, Tzong-Shin Tzai, Chein-Hung Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：前列腺癌和良性前列腺增生样品的尿道前列腺特异性抗原糖族分析
5. The long-term cost-effectiveness of treatments for benign prostatic hyperplasia. [D] . DiSantostefano, Rachael Lynn. 2005

机译：良性前列腺增生治疗的长期成本效益。
6. Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia [O] . James C Ulchaker, Melissa S Martinson 2018

机译：六种治疗前列腺增生症下尿路症状的方法的成本效益分析
7. Estimating The Economic Benefit Of Treatment With Alpha-Blocker Plus Antimuscarinic As A Fixed-Dose Combination (FDC) Tablet Versus Concomitant Combination Therapy (CCT) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (BPH) [O] . S Bowditch, C McCrea, E Arbe, 2017

机译：估计α-嵌体加抗血清胰岛素作为固定剂量组合（FDC）片剂的经济效益，与患有良性前列腺增生（BPH）相关的男性的伴随组合治疗（CCT），伴随着尿路症状（LUT）

PUK9 COST-EFFECTIVENESS ANALYSIS OF ALPHA-BLOCKER AND ANTIMUSCARINIC COMBINATION TREATMENT IN MEN WITH LOWER URINARY TRACT SYMPTOMS RELATED TO BENIGN PROSTATIC HYPERPLASIA AND OVERACTIVE BLADDER: APPLICATION TO THE UNITED KINGDOM

著录项

引文网络

相似文献

相关主题

期刊订阅